-
Studies on inhibition of neutrophil cathepsin G by alpha 1-antichymotrypsin.
Inflammation. 1995 Feb;19(1):75-81
PMID: 7705888
-
Reaction of human chymase with reactive site variants of alpha 1-antichymotrypsin. Modulation of inhibitor versus substrate properties.
J Biol Chem. 1993 Nov 5;268(31):23626-33
PMID: 8226889
-
Subtilisin BPN': kinetic study with oligopeptides.
Arch Biochem Biophys. 1970 Jun;138(2):515-25
PMID: 5433586
-
An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'.
Biochemistry. 1972 Jun 20;11(13):2439-49
PMID: 5040650
-
Human leukocyte granule elastase: rapid isolation and characterization.
Biochemistry. 1976 Feb 24;15(4):836-41
PMID: 1082346
-
Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.
J Biol Chem. 1980 May 10;255(9):3931-4
PMID: 6989830
-
Human plasma proteinase inhibitors.
Annu Rev Biochem. 1983;52:655-709
PMID: 6193754
-
Amino acid sequence at the reactive site of human alpha 1-antichymotrypsin.
J Biol Chem. 1983 Nov 10;258(21):12749-52
PMID: 6556193
-
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.
J Mol Biol. 1984 Aug 15;177(3):531-57
PMID: 6332197
-
Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues.
Biochemistry. 1987 Jan 13;26(1):202-21
PMID: 3828298
-
Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.
J Biol Chem. 1987 Jul 25;262(21):10035-8
PMID: 3611052
-
Stoichiometry of the interaction of human plasma alpha 1-proteinase inhibitor with subtilisin BPN'.
J Biochem. 1989 Jan;105(1):66-71
PMID: 2661553
-
Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors.
J Biol Chem. 1989 Dec 15;264(35):21308-15
PMID: 2592376
-
Cloning, expression, purification, and biological activity of recombinant native and variant human alpha 1-antichymotrypsins.
J Biol Chem. 1990 Jan 15;265(2):1199-207
PMID: 2404007
-
Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.
Biochemistry. 1991 Jan 29;30(4):979-86
PMID: 1703440
-
Mammalian subtilisins: the long-sought dibasic processing endoproteases.
Cell. 1991 Jul 12;66(1):1-3
PMID: 2070411
-
Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.
Biochemistry. 1991 Sep 10;30(36):8876-82
PMID: 1888745
-
Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor).
Protein Eng. 1991 Jun;4(5):501-8
PMID: 1891457
-
Natural protein proteinase inhibitors and their interaction with proteinases.
Eur J Biochem. 1992 Mar 1;204(2):433-51
PMID: 1541261
-
Homology modelling and protein engineering strategy of subtilases, the family of subtilisin-like serine proteinases.
Protein Eng. 1991 Oct;4(7):719-37
PMID: 1798697
-
Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis.
Biochemistry. 1992 Mar 17;31(10):2720-8
PMID: 1547212
-
Extensive comparison of the substrate preferences of two subtilisins as determined with peptide substrates which are based on the principle of intramolecular quenching.
Biochemistry. 1992 Jul 7;31(26):6011-8
PMID: 1627543
-
Interdependency of the binding subsites in subtilisin.
Biochemistry. 1992 Sep 22;31(37):8967-71
PMID: 1390683
-
Structure and mechanism of action of serpins.
Hematol Oncol Clin North Am. 1992 Dec;6(6):1393-408
PMID: 1452519
-
Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant.
J Biol Chem. 1993 Nov 25;268(33):24887-91
PMID: 8227051
-
Furin has the proalbumin substrate specificity and serpin inhibitory properties of an in situ hepatic convertase.
FEBS Lett. 1994 Jan 31;338(2):147-51
PMID: 8307172
-
Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways.
Biochemistry. 1994 Jul 19;33(28):8538-47
PMID: 8031789
-
Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b.
Biochim Biophys Acta. 1994 Jun 30;1222(2):179-86
PMID: 8031854
-
Biological implications of a 3 A structure of dimeric antithrombin.
Structure. 1994 Apr 15;2(4):257-70
PMID: 8087553
-
Families of serine peptidases.
Methods Enzymol. 1994;244:19-61
PMID: 7845208
-
What do dysfunctional serpins tell us about molecular mobility and disease?
Nat Struct Biol. 1995 Feb;2(2):96-113
PMID: 7749926
-
Structural basis of substrate specificity in the serine proteases.
Protein Sci. 1995 Mar;4(3):337-60
PMID: 7795518
-
The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions.
Nat Struct Biol. 1994 Jan;1(1):48-54
PMID: 7656006
-
Serpin-protease complexes are trapped as stable acyl-enzyme intermediates.
J Biol Chem. 1995 Oct 27;270(43):25309-12
PMID: 7592687
-
Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.
Protein Sci. 1993 May;2(5):786-99
PMID: 8495199
-
Antichymotrypsin interaction with chymotrypsin. Partitioning of the complex.
J Biol Chem. 1993 Nov 5;268(31):23616-25
PMID: 7693693
-
Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus.
J Virol. 1995 May;69(5):3206-10
PMID: 7707552